Johnson & Johnson

Strategic intent

Johnson & Johnson is a global healthcare giant focused on developing, manufacturing, and selling prescription pharmaceuticals (Innovative Medicine) and medical devices (MedTech) globally.

Key market signals

• 2026-10: Johnson & Johnson announced positive clinical data for JNJ-6143, a first-in-class RIPTAC molecule showing a 75% tumor response rate in advanced prostate cancer.
• 2026-10: Johnson & Johnson launched its next-generation Shockwave C2 Aero Fly Coronary IVL Catheter in the U.S., designed to cut treatment time in half.
• 2026-10: Johnson & Johnson presented positive real-world clinical data for its VARIPULSE Pro and OMNYPULSE pulsed field ablation (PFA) platforms for atrial fibrillation.
• 2026-07: Johnson & Johnson proposed a $5.5 billion settlement to resolve approximately 76,000 ovarian cancer talc lawsuits outside of bankruptcy, which has ongoing impact as it awaits final approval.
• 2025-10: Johnson & Johnson announced its intent to separate its Orthopaedics business (DePuy Synthes) into a standalone company by mid-2027 to focus on higher-growth MedTech and Innovative Medicine markets.

Financial health

• Q3 2026 reported sales grew 5.9% year-over-year to $25.40 billion (https://www.jnj.com)
• GAAP net earnings for Q3 2026 were $210 million, down 95.9% year-over-year, reflecting a one-time special charge for proposed talc litigation resolution (https://www.jnj.com)
• Full-year 2026 guidance was raised to estimated reported sales of $101.0 billion to $101.4 billion, representing a midpoint of $101.2 billion (https://www.jnj.com)

Impact & compliance

Legal & risks

In December 2025, a Baltimore jury ordered J&J to pay $1.56 Billion to a mesothelioma victim who alleged that the company failed to warn that its baby powder contained asbestos. In its 10-K filed on February 13, 2025, Johnson & Johnson disclosed that the DOJ had informed the company that […]

Forensic audit — 3 findings

• ⚠ In October 2025, New Jersey's Department of Environmental Protection (NJDEP) sued Pfizer, Johnson & Johnson, Honeywell,
• ⚠ In June 2025, America First Legal (AFL) filed a civil rights complaint against Johnson & Johnson with the Department of
• ⚠ In May 2026, the SpaceBears ransomware group claimed to have targeted Johnson & Johnson Innovative Medicine, exfiltratin...

🔒 Proprietary analysis

Proprietary Analysis — available with full access

Want the full analysis?

Get access to strategic fit scoring, cultural fit analysis, full forensic detail, and alignment dimensions.